Primary pulmonary hypertension (PPH) is a progressive disease of unknownetiology usually followed by death within 5 years after diagnosis. Although heart-lung or lung transplantation is nowoffered to patients with advancedPPH,adequate criteria assessing an accurate prediction of life expectancy in PPHhas been difficult to establish. The aims of this study were to identify the characteristic features associated with a poor prognosis in patients with PPH, and to attempt to establish an individual prognostic index that predicts with great accuracy survival or death ofPPH after one year, thereby helping to define criteria for patient selection for transplantation. In 1991, a retrospective nation-wide survey on PPHwas conducted in Japan, and the clinical and cardiorespiratory variables of223 PPH cases (female; 144, male; 79) in the period from 1980-1990 were obtained. The mean pulmonary arterial pressure (Ppa) was 57.5 ± 17.2 mmHg(mean ± SD), and the overall median survival time was 32.5 months since the first diagnostic catheterization. The characteristic features of 61 patients who died within one year of catheterization (Nonsurvivors group) were compared to 141 patients whosurvived one year or more from the time of catheterization (Survivors group). Amongseveral clinical and cardiorespiratory variables, heart rate, Ppa, right atrial pressure (Pra), stroke volume index (SI), pulmonary vascular resistance, and partial pressure of carbon dioxide (PaCO2) were significantly different between the two groups. As the independent factors, Ppa, Pra, SI, and PaCO2were selected for the multiple logistic analysis. Using a 0.7 probability cut-point to separate Nonsurvivors from Survivors, 84.6% of Nonsurvivors and Survivors could be correctly predicted from this logistic regression equation. Predictive equations like the present preliminary one can be used in the future to better assess life expectancy in patients with PPHin whomtransplantation will be considered. (Internal Medicine 38: 12-16, 1999) 
Introduction
Primary pulmonary hypertension (PPH) is characterized by a progressive elevation in pulmonary arterial pressure and pulmonary vascular resistance that eventually leads to right ventricular failure and death within 5 years after diagnosis (1 , 2) . Although medical treatment for this disease has improved dramatically over the past decade, resulting in sustained clinical improvement and prolongation of life in a substantial percent of patients (3, 4) , there is no medical therapeutic approach which is uniformly accepted or successful. Recently, heart-lung or lung transplantation has provided a newtherapeutic option for the increasing number of patients with end-stage pulmonary vascular disorders (5, 6) . However, since the number of potential recipients of lung transplantation has greatly exceeded the supply of available donor organs, some form of priority assignment for lung transplantation is necessary (7, 8) .
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Prediction of Life Expectancy in PPH
Although a predicted life expectancy of less than 12 to 24 months is usually considered to be one of the selection criteria for transplantation candidates, the adequate criteria to assess an accurate prediction of life expectancy in patients with PPHhas been difficult to establish. In previous reports several factors found to be associated with increased mortality include hemodynamic variables (9-1 1), use of oral contraceptives (12) , family history of PPH (9) , and pregnancy (13) . The National American Prospective Registry for PPH recently proposed that mortality in PPHcan be characterized by means of an equation using three hemodynamicvariables: meanpulmonary arterial pressure, mean right atrial pressure, and cardiac output (14) . However, this proposed prognostic equation had a high sensitivity and a relative low specificity to predict survival in other PPHpopulations (15) . Moreover, spontaneous patient improvement or stabilization, that was recognized in some cases ofPPH, makes it difficult to predict the precise prognosis in the individual patient (9, 10) .
To obtain an accurate prediction of life expectancy of PPH in a large population, a retrospective nationwide survey on PPH was conducted in Japan; the clinical and cardiorespiratory data were collected and analyzed.
Subjects and Methods
In 1991, a retrospective nationwide survey on PPHwas undertaken in major cardiorespiratory institutions from which any clinical report with respect to PPHhad been presented. Every institution was visited by membersof our department to obtain the clinical records on all patients with PPHobserved in those institutions, in the period 1980-1990. The clinical data set included clinical history and physical examination, outcome, laboratory findings , pulmonary function tests , and hemodynamic variables at the first cardiac catheterization. In somepatients, ventilation/perfusion lung scan or pulmonary angiogram was also reviewed to exclude chronic thromboembolic pulmonary hypertension or pulmonary arteritis. As in other studies (15, 16) , criteria used to establish the diagnosis of PPHincluded the presence of a mean pulmonary arterial pressure of greater than 25 mmHgat rest, a normal pulmonary capillary wedge pressure whenmeasurable, and the absence of other diseases knownto cause or to be associated with secondary pulmonary hypertension. Particular care was taken to exclude patients with chronic thromboembolic disease, congenital heart disease or acquired valvular disease, clearly defined collagen vascular disease, or portal hypertension. For the survival analysis, the date of the initial diagnostic catheterization was used as an index for determining survival. The Kaplan-Meiermethodwas applied to estimate the overall survival distribution.
To identify the characteristic features associated with a poor prognosis in patients with PPH, demographic, hemodynamic and pulmonary function variables were compared between those whosurvived one year or more (Survivors group) and those whodied within one year ofcatheterization (Nonsurvivors group). All variables that achieved statistical significance (p<0.05) in the univariate analysis using the MannWhitney U test for unpaired data were subsequently included in multivariate analysis to examine the independent effect on survival of each variable. The independent variables were finally entered into the multiple logistic analysis to establish an individual prognostic index that predicts survival or death ofPPH after one year of catheterization.
Results
From 143 cardiorespiratory institutions, the clinical records on 272 cases of suspected PPHwere collected, and 223 patients fulfilled the diagnostic criteria for PPH. In the other 49 patients, collagen vascular disease was probable in 19 cases, pulmonary hypertension associated with portal hypertension in 1 2 cases, and 7 patients were diagnosed as chronic thromboembolic pulmonary hypertension. The age and sex distribution of the 223 patients with PPH are shown in Fig. 1 . The mean age of223 patients was 28.4± 1 7.0years (mean± SD; range, 0to 73 years), and the overall female-to-male ratio was 1.82:1. A high frequency in the third and fourth decade, in which womenwere predominant, was observed, and patients in the first and second decade showeda similar sex distribution. The meantime from onset of the first symptom to diagnosis ofPPH was 2.27 ± 3.05
years.
Cardiorespiratory variables at the initial diagnostic catheterization are shown in Table 1 . The patients had severe pulmonary arterial hypertension with a three-fold increase in mean pulmonary arterial pressure (57.5 ± 17.2 mmHg;range: 25 to 123 mmHg)with normal pulmonary capillary wedge pressure (7.3 ± 3.5 mmHg), and mildly reduced to normal cardiac indexes (2.7 1 ± 1.02 //min/m2; range: 0.96 to 6.47 l/min/ m2). There was a mild reduction in forced vital capacity (mean: 90.4% of predicted), and a mild-to-moderate decrease in arterial blood oxygen pressure (PaO2: 69.7 ± 13.3 mmHg) and carbon dioxide pressure (PaCO2: 32.3 ± 4.9 mmHg). Age (years) Figure 1 . The age and sex distribution of 223 patients with primary pulmonary hypertension. The mean age was 28.4 ± 17.0 years (mean ± SD) and female-to-male ratio was 1.82:1. Time from the first catheterization Figure 2 . The overall cumulative survival curve of 201 patients with primary pulmonary hypertension in which 22 patients whose causes of death were not identified to be related to pulmonary hypertension were excluded. The estimated median survival time was 33.0 months and the estimated percentage of patients surviving at 5 years was 42.5%. (Table 4) . On a prospective basis, moreover, 100% (8/8) of predicted Nonsurvivors would be expected to die within one year of the initial diagnostic catheterization. 
Discussion
Although primary pulmonary hypertension had been considered a uniformly fatal disease with a poor prognosis in the range of one to three years from diagnosis or three to five years from the onset of symptoms(1, 2, 16), there were also PPH patients for whomsurvival exceeded 5 to 10 years (9, ll), or even spontaneousregression of the disease waswell documented (17) . This diversity of prognosis in PPH is related to the possibility that clinically diagnosed PPH might be more than one disease (1 1), since the diagnosis ofPPH is usually reached by exclusion of secondary pulmonary hypertension. Therefore, to establish an individual prognostic index that would predict with great accuracy death or survival of PPHpatients after one year of the initial diagnostic catheterization can be of considerable value in the planning of treatment strategies including heart-lung or lung transplantation. In Japan, the first nationwide questionnaire survey on PPH was conducted in 1975-1977, and a total of 131 patients with PPHwere collected and reported ( 1 8) . Although the age and sex distributions of these 13 1 PPHpatients are thought to be similar to the present PPHseries, the causes of death in the first survey are somewhat different from the present survey. According to the early report, causes of death in 70 deceased patients were right heart failure in 37 (52.9%) and sudden death related to cardiac catheterization or pulmonary angiography in 26 (37. 1 %). In our PPHseries, there were only 4 deaths (2.9%) associated with these procedures and 2 patients had died within one year after the initial diagnostic catheterization. Manyclinical reports have demonstrated that hemodynamic variables that assess right ventricular performance, such as cardiac output, or right atrial pressure, are major prognostic factors inpatients withPPH (2, 9, ll, 14, 15, 19) . In additionto those hemodynamic factors, the New York Heart Association (NYHA) functional class (14, 19) , mixed venous oxygen pressure (15) , and diffusing capacity for carbon monoxide (14) have been suggested to have a close association with the prognosis in PPH. To identify the prognostic factors associated with a short survival in our patients with PPH, clinical and cardiopulmonary variables were comparedbetween patients whodied within one year from the time of initial diagnostic catheterization (Nonsurvivors) and those who survived at least one year after catheterization (Survivors). In this study, a survival duration of one year was chosen for the borderline between two groups, because we believe that patients who have a predicted life expectancy of less than 12 months should be selected for heartlung or lung transplantation and should receive particular attention. In accordance with other studies, the Nonsurvivors group had a significantly higher heart rate, right atrial pressure, pulmonary arterial pressure, and pulmonary vascular resistance, and lower stroke volume index. Unexpectedly, the cardiac index, which is generally accepted to be one of the major prognostic factors, did not significantly differ between two groups. Although the higher frequency in the first decade on the age distribution might be related to this discrepancy, the precise reasons are not clearly identified. An additional prognostic factor found in the present study is arterial blood carbon dioxide pressure (PaCO2) which was not correlated with any of the other prognostic variables.
The results of the present logistic analysis should be interpreted cautiously in light of the small number of patients actually analyzed (total of 65 patients out of 223 PPH patients).
Of the many factors influencing survival at one year after catheterization, mean pulmonary arterial pressure, right atrial pressure, stroke volumeindex and PaCO2were selected for the multiple logistic analysis in this study. It might be better to use other indices that indicate right ventricular function in PPH patients. And also, the criteria which separate the grading scores were somewhatarbitrary. However,we believe that, in order to recognize the prognosis of each patient, it will be better to use the grading scores than the absolute numbersof those four variables. Using a 0.7 probability cut-point to separate Nonsurvivors from Survivors, 84.6% of observed Nonsurvivors and Survivors could be correctly predicted from this logistic regression equation. This equation was achieved by the data of only 65 patients (29.1%) in this series. A predictive equation like the present preliminary one can be used in the future to better assess life expectancy in patients with PPHin whom transplantation will be considered.
